Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study

The aim of this prospective open-label study was to treat disabling drooling in children with cerebral palsy (CP) with onabotulinumtoxin A (A/Ona, Botox(®)) into submandibular and parotid glands and find the lowest effective dosage and least invasive method. A/Ona was injected in 14 children, Mean a...

Descripción completa

Detalles Bibliográficos
Autores principales: Møller, Eigild, Pedersen, Søren Anker, Vinicoff, Pablo Gustavo, Bardow, Allan, Lykkeaa, Joan, Svendsen, Pia, Bakke, Merete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516924/
https://www.ncbi.nlm.nih.gov/pubmed/26134257
http://dx.doi.org/10.3390/toxins7072481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516924/
https://www.ncbi.nlm.nih.gov/pubmed/26134257
http://dx.doi.org/10.3390/toxins7072481

Ejemplares similares